BTMD — biote Income Statement

0.000.00%

Last trade - 00:00

IndustrialsAdventurousSmall CapContrarian

Annual income statement for biote, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	117	139	165	185	197
Cost of Revenue
Gross Profit	71.6	90.6	110	127	139
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	84.8	105	226	157	166
Operating Profit	31.8	34.6	-61.2	28.7	31.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	29.4	32.9	1.71	-0.123	1.02
Provision for Income Taxes
Net Income After Taxes	29.2	32.6	1.32	-2.81	0.046
Minority Interest
Net Income Before Extraordinary Items
Net Income	29.2	32.6	-0.969	3.32	3.16
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	29.2	32.6	-0.969	3.32	3.16
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.5	3.41	-2.22	0.488	0.316
Dividends per Share